Tag Archives: Chronic

Reviewing Interventional Treatments for Chronic Headache – Medical Bag

When chronic headaches and facial pain are complicated by comorbidities, polypharmacy, intolerance, or refractory pain, some clinicians are turning to interventional modalities to ease headache pain.1 Patients who cannot get relief with acute treatment were found to be 2 to 3 times more likely to transition to chronic migraine.2 Interventions to treat the most common… Read More »

Behavioral Chronic Migraine Treatment a Cost Effective Alternative

Behavioral chronic migraine treatment such as relaxation training, hypnosis and biofeedback makes financial sense in comparison to prescription medication, particularly after a year or longer. The costs of prescription medications, the type chronic migraine sufferers use on a daily basis in order to prevent onset, might not appear to be much even at a few… Read More »

Chronic pain relief: Mindfulness may be just as good as CBT

New research appearing in the BMJ journal Evidence-Based Mental Health suggests that mindfulness could be a promising alternative to cognitive behavioral therapy for relieving some of the psychological and physical symptoms of chronic pain. Mindfulness may be a useful alternative to CBT for easing chronic pain, new research shows. According to the most recent survey… Read More »

Study links drinking too much beer and tea to chronic kidney disease

A new study has shown that drinking too much tea or beer can lead to chronic kidney disease. This is the perfect excuse to start your 2019 resolutions of right! Researchers from Johns Hopkins Bloomberg School of Public Health, in Baltimore, examined survey data on drink consumption among 3,003 African-American men and women who all had kidney… Read More »

FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC)

FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC) Print this page Cambridge, Mass. – December 17, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) has announced that the U.S. Food and Drug Administration (FDA) has approved Motegrity™ (prucalopride), a once-daily, oral treatment option for adults with Chronic Idiopathic Constipation (CIC).1 Motegrity, a… Read More »